Improving the Clinical Encounter to Enhance Delivery of an Individualized Prematurity Prevention Plan
1 other identifier
interventional
30
1 country
1
Brief Summary
The purpose of this study is to pilot an intervention that was developed to improve uptake and adhere to an Individualized Prematurity Prevention Plan (IP3) for preterm birth prevention. Non-Hispanic Black (NHB) women are at higher risk for preterm birth compared to other racial and ethnic groups. Building on qualitative data from NHB women with input from a multidisciplinary stakeholder group, a patient-centered intervention was developed to improve uptake and adherence to an IP3 in NHB women.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Feb 2020
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 11, 2019
CompletedFirst Posted
Study publicly available on registry
November 4, 2019
CompletedStudy Start
First participant enrolled
February 1, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2021
CompletedResults Posted
Study results publicly available
November 2, 2022
CompletedNovember 2, 2022
November 1, 2022
1.2 years
October 11, 2019
March 31, 2022
November 1, 2022
Conditions
Outcome Measures
Primary Outcomes (2)
Feasibility as Measured by Number of Recruited Eligible Patients Enrolled
Enrollment target of 30% of eligible patients recruited.
study duration (approximately 14 months)
Acceptability as Measured by Number of Participants Who Completed the Study
Completion target of 80% participants retained in study protocol.
study duration (approximately 14 months)
Secondary Outcomes (10)
IP3 Adherence as Measured by Number of Participants With Patient and EMR (Electronic Medical Record) Report of Medication Compliance
approximately 1 year
Pregnancy Specific Anxiety (PSA)
baseline, 28 weeks
Interpersonal Process of Care (IPC-18) at Protocol Completion - Communication Domain
protocol completion (approximately 1 year)
Interpersonal Process of Care (IPC-18) at Protocol Completion - Decision Making Domain
protocol completion (approximately 1 year)
Interpersonal Process of Care (IPC-18) at Protocol Completion - Interpersonal Style Domain
protocol completion (approximately 1 year)
- +5 more secondary outcomes
Study Arms (2)
Intervention Arm: Weekly IP3 text messages
OTHER* A narrated powerpoint presentation describing the logistical details and medical rationale for components of the IP3. Participants will view the chapters of the presentation that are relevant to their specific IP3. There are a total of 4 possible chapters (lifestyle modifications, cervix length screening/cerclage, progesterone therapy, low dose aspirin). Each chapter of the presentation is \~ 10 - 15 min in length. Each chapter also includes a 4- 5 questions pre-test and the same questions are delivered as a post-test after the presentation. * Print materials including a letter explaining the importance of prenatal care for preterm birth prevention to employers. * Text messages sent weekly to encourage the patient to continue with their IP3 and provide basic pregnancy information * Formal letter of encouragement from provider at 28 weeks gestation
Control Arm: General pregnancy text messages
ACTIVE COMPARATOR* a pre-intervention questionnaire * a narrated powerpoint with general information about the clinic * a post-presentation questionnaire * text messages sent approximately weekly with general pregnancy information (e.g. today your baby is about the size of an apple) * an exit interview
Interventions
Subjects will be provided with a pre and post intervention survey, in addition to a narrated Powerpoint presentation focusing on the logistics of their IP3. Subjects will also receive weekly automated text messages to encourage adherence to the need for their IP3.
Subjects will be given pre and post pre questionnaires, in addition to a narrated Powerpoint presentation about the Clinic. Subjects will also be sent weekly text messages with general pregnancy information.
Eligibility Criteria
You may qualify if:
- self described race as Non-Hispanic Black
- history of prior singleton preterm delivery (before 37 weeks gestation)
- current singleton gestation
You may not qualify if:
- women with anomalous fetuses
- age below 18\]
- non-English speaking
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Duke Universitylead
Study Sites (1)
Duke University
Durham, North Carolina, 27705, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Sarahn M. Wheeler, MD
- Organization
- Duke University
Study Officials
- PRINCIPAL INVESTIGATOR
Sarahn Wheeler, MD
Duke University
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 11, 2019
First Posted
November 4, 2019
Study Start
February 1, 2020
Primary Completion
April 1, 2021
Study Completion
April 1, 2021
Last Updated
November 2, 2022
Results First Posted
November 2, 2022
Record last verified: 2022-11
Data Sharing
- IPD Sharing
- Will not share